EffPha – 以專家為核心的臨床試驗受託機構(CRO),協助您的藥物研發
Exhibitor: EFFICIENT PHARMA MANAGEMENT CORP.
Date: 2026-06-30
Booth No.: M1117
Efficient Pharma Management Corp. (EffPha) is a full-service CRO providing drug development services, including strategic and technical consulting, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has established a team of experts with over 30 years of drug development experience from global pharmaceutical companies since founded. That EffPha is an expert-based CRO is the brand positioning by providing advice based on practical industry experience from domestic and international new drug development companies.
We knew an experienced and talented drug development team can not only provide decision-makers with the best strategies of drug development, advise and direct clinical operations, but also identify potential risks in drug development, which allows them to further plan risk management or adjust the direction of product development. Therefore, it would help shorten drug development timelines and mitigate risks for biotech and pharmaceutical companies, allocating development resources more efficiently.
EffPha excels at proposing the most suitable drug development strategies, designing clinical trials with high success rates, and providing high-quality clinical trial monitoring and management for the purpose of providing clients with the most efficient services. In recent years, clinical trials have tended to be conducted in multiple countries. In response, EffPha has set its sights on the global market. EffPha has taken the initiative to build a global presence, expand CRO services for international multi-center clinical trials, and move forward with our long-term collaborative pharmaceutical partners.
Visit us to learn how EffPha can help support your drug development projects at https://www.effpha.com/.
More Exhibitor's Press Release
- NYCU Pavilion at BIO Asia–Taiwan 2026 NATIONAL YANG MING CHIAO TUNG UNIVERSITY / 2026-06-30
- EffPha Meets You at BIO Asia-Taiwan Exhibition 2026 EFFICIENT PHARMA MANAGEMENT CORP. / 2026-06-30
- LabWare European and North American Customer Education Conferences Conclude LABWARE TAIWAN CO., LTD. / 2026-06-29
- Integrated Bio × Lingan Water-Free Cell Thawing Solution INTEGRATED BIO LTD. / 2026-06-29
- LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025 LABWARE TAIWAN CO., LTD. / 2026-06-22
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser EG BIOMED US INC. / 2026-06-15
- Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science EG BIOMED US INC. / 2026-06-15
- 2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-04
- Botanical Drug GM-XANTHO® Completes Phase I/IIa Trial for Atopic Dermatitis XANTHO BIOTECHNOLOGY CO., LTD. / 2026-06-04
- ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readines PROBIO TECHNOLOGY HK LIMITED. / 2026-06-04
- LIS TECH Showcases Regenerative Medicine and Bioprocessing Platform at BIO Asia–Taiwan 2026 LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- GeniCore Biotech Unveils Its AI-Powered Genimer™ Aptamer Platform LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- Medidata’s Digital Oversight Platform Empowers Pharma and CROs to Align with Next-Gen GCP MEDIDATA / 2026-06-02
- Medidata Powers Transformational Breakthroughs in Over 500 Global Clinical Trials with AI MEDIDATA / 2026-06-02